It has been recently demonstrated that HER2 CAR-expression in NK cells from healthy donors and patients with breast cancer potently enhances their anti-tumor functions against various HER2-expressing cancer cells, regardless of MHC class I expression (124). Here, ERBB2 is linked to cancer.